113 related articles for article (PubMed ID: 23107278)
1. Real-world effectiveness of clozapine in patients with bipolar disorder: results from a 2-year mirror-image study.
Nielsen J; Kane JM; Correll CU
Bipolar Disord; 2012 Dec; 14(8):863-9. PubMed ID: 23107278
[TBL] [Abstract][Full Text] [Related]
2. Predictors of clozapine response in patients with treatment-refractory schizophrenia: results from a Danish Register Study.
Nielsen J; Nielsen RE; Correll CU
J Clin Psychopharmacol; 2012 Oct; 32(5):678-83. PubMed ID: 22926603
[TBL] [Abstract][Full Text] [Related]
3. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
4. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
Mercier C; Bret P; Bret MC; Queuille E
Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
[TBL] [Abstract][Full Text] [Related]
5. Real-World Effectiveness of Clozapine for Borderline Personality Disorder: Results From a 2-Year Mirror-Image Study.
Rohde C; Polcwiartek C; Correll CU; Nielsen J
J Pers Disord; 2018 Dec; 32(6):823-837. PubMed ID: 29120277
[TBL] [Abstract][Full Text] [Related]
6. Real-world effectiveness of clozapine for intellectual disability: Results from a mirror-image and a reverse-mirror-image study.
Rohde C; Hilker R; Siskind D; Nielsen J
J Psychopharmacol; 2018 Nov; 32(11):1197-1203. PubMed ID: 29944071
[TBL] [Abstract][Full Text] [Related]
7. Clozapine use reduced psychiatric hospitalization and emergency room visits in patients with bipolar disorder independent of improved treatment regularity in a three-year follow-up period.
Wu CS; Wang SC; Liu SK
Bipolar Disord; 2015 Jun; 17(4):415-23. PubMed ID: 25295837
[TBL] [Abstract][Full Text] [Related]
8. Clozapine for treatment-resistant bipolar disorder: a systematic review.
Li XB; Tang YL; Wang CY; de Leon J
Bipolar Disord; 2015 May; 17(3):235-47. PubMed ID: 25346322
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation.
Carlson PJ; Merlock MC; Suppes T
Bipolar Disord; 2004 Oct; 6(5):416-20. PubMed ID: 15383134
[TBL] [Abstract][Full Text] [Related]
10. Response to clozapine of rapid cycling versus non-cycling patients with a history of mania.
Suppes T; Ozcan ME; Carmody T
Bipolar Disord; 2004 Aug; 6(4):329-32. PubMed ID: 15225152
[TBL] [Abstract][Full Text] [Related]
11. Effects of clozapine on sleep in bipolar and schizoaffective disorders.
Armitage R; Cole D; Suppes T; Ozcan ME
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1065-70. PubMed ID: 15610918
[TBL] [Abstract][Full Text] [Related]
12. Geographical and temporal variations in clozapine prescription for schizophrenia.
Nielsen J; Røge R; Schjerning O; Sørensen HJ; Taylor D
Eur Neuropsychopharmacol; 2012 Nov; 22(11):818-24. PubMed ID: 22503785
[TBL] [Abstract][Full Text] [Related]
13. Enhanced ziprasidone combination therapy effectiveness in obese compared to nonobese patients with bipolar disorder.
Miller S; Ittasakul P; Wang PW; Hill SJ; Childers ME; Rasgon N; Ketter TA
J Clin Psychopharmacol; 2012 Dec; 32(6):814-9. PubMed ID: 23131875
[TBL] [Abstract][Full Text] [Related]
14. Outcomes for schizophrenia patients with clozapine treatment: how good does it get?
Wheeler A; Humberstone V; Robinson G
J Psychopharmacol; 2009 Nov; 23(8):957-65. PubMed ID: 18635713
[TBL] [Abstract][Full Text] [Related]
15. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
16. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
17. [Medico-economic study of Léponex (clozapine) in the Bordeaux Charles Perrens Hospital Center].
Bret P; Jolivel C; Bret MC; Veylit S; Martin C; Garcia P
Encephale; 1998; 24(4):365-77. PubMed ID: 9809242
[TBL] [Abstract][Full Text] [Related]
18. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
[TBL] [Abstract][Full Text] [Related]
19. Is clozapine a mood stabilizer?
Zarate CA; Tohen M; Banov MD; Weiss MK; Cole JO
J Clin Psychiatry; 1995 Mar; 56(3):108-12. PubMed ID: 7883728
[TBL] [Abstract][Full Text] [Related]
20. Retrospective review of clozapine in the treatment of patients with autism spectrum disorder and severe disruptive behaviors.
Beherec L; Lambrey S; Quilici G; Rosier A; Falissard B; Guillin O
J Clin Psychopharmacol; 2011 Jun; 31(3):341-4. PubMed ID: 21508854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
